President & General Manager
Almirall US
Paul Rittman is an experienced pharma executive with over 13 years in general management, leading business units in the US and Canada. He joined the pharmaceutical industry more than 30 years ago and holds a BA from the University of Missouri and an MBA from St. Ambrose University. Paul’s career spans multiple sales, marketing, and management roles across therapeutic areas such as dermatology, oncology, hematology, neurology, cardiology, gastroenterology, allergy, and rheumatology.
Before joining Almirall, Paul was President and CEO of Helsinn Therapeutics US and served on its Board of Directors. He also previously led the Teva US Branded Oncology/Hematology business unit as SVP and General Manager. At Almirall, Paul leverages his strategic vision and industry experience to drive growth and innovation for the US affiliate.
